These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Tetracosactide in the treatment of rheumatoid arthritis and gout]. Usobiaga JL Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406 [No Abstract] [Full Text] [Related]
4. Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup. Taylor WJ; Rajapakse CN; Harris KA; Harrison AA; Corkill MM J Rheumatol; 1999 Dec; 26(12):2544-50. PubMed ID: 10606361 [TBL] [Abstract][Full Text] [Related]
5. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction]. Kropp R Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022 [TBL] [Abstract][Full Text] [Related]
6. [Clinical experiences with 5% Tolectin (tolmetin) gel in patients with degenerative joint and spine diseases and soft tissue rheumatism]. Fellmann N Z Rheumatol; 1983; 42(5):280-4. PubMed ID: 6606279 [TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity. Glass D; Roffe L; Maini RN; Wraith DG; Nuki G Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487 [TBL] [Abstract][Full Text] [Related]
8. [Synacthen depot in the treatment of psoriatic arthritis]. Chichenina IV; Rakhmatov AB Vestn Dermatol Venerol; 1988; (9):64-6. PubMed ID: 3213224 [No Abstract] [Full Text] [Related]
9. [Management of soft-tissue rheumatism using a indomethacin-dexa-methasone (Deca-amuno) conbination]. Müller G Munch Med Wochenschr; 1973 May; 115(20):950-1. PubMed ID: 4541569 [No Abstract] [Full Text] [Related]
10. [New acquisition in the therapy of rheumo-arthritic diseases]. Mascio G Minerva Med; 1973; 64(48):2541-54. PubMed ID: 4269470 [No Abstract] [Full Text] [Related]
11. [Treatment in rheumatology with a new injectable salt of indomethacin]. Coari G; Taccari E Minerva Med; 1974 Mar; 65(17):917-22. PubMed ID: 4545238 [No Abstract] [Full Text] [Related]
12. [Use of delayed-action Cortrosyn (Tetracosactide) in rheumatology. Apropos of 32 cases]. Lièvre JA; Guillien P Brux Med; 1970 Dec; 50(12):1103-12. PubMed ID: 4322894 [No Abstract] [Full Text] [Related]
13. [Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial]. Napoli A; Alderuccio B; Nannetti A Clin Ter; 1977 Dec; 83(5):541-7. PubMed ID: 343972 [No Abstract] [Full Text] [Related]
14. [Tetracosactide (Synacthen Depot) in patients with multiple sclerosis]. Kanić M; Sepcić J Lijec Vjesn; 1992; 114(5-8):134-6. PubMed ID: 1343045 [TBL] [Abstract][Full Text] [Related]
15. [Ibuprofen for the therapy of soft-tissue rheumatism]. Siegmeth W Ther Ggw; 1973 Aug; 112(8):1306 passim. PubMed ID: 4543199 [No Abstract] [Full Text] [Related]
16. Proglumetacin (protacine): a promising new treatment of the rheumatic joint. Rivera IC Pharmatherapeutica; 1982; 3(3):169-73. PubMed ID: 6982477 [TBL] [Abstract][Full Text] [Related]
17. [Stimulation of the adrenal cortex in long-term steroid therapy. Increase of free cortisol in the urine following depot ACTH administration]. Nolte D; Gallenberger S; Borgolte H; Vecsei P; Haack D Fortschr Med; 1986 Jun; 104(22):444-7. PubMed ID: 3017824 [No Abstract] [Full Text] [Related]
18. [Study of the efficacy and tolerance of a medullary extract in the treatment of chronic rheumatism]. Ravina A Presse Med (1893); 1967 Nov; 75(48):2471-2. PubMed ID: 5299715 [No Abstract] [Full Text] [Related]
19. [Joint pain crises and chronic inflammatory-reactive phenomena: a unitary approach with proglumetacin]. Larosa F; Vittore D; Mazzarisi A; Molfetta L Minerva Med; 1983 Jun; 74(26):1535-8. PubMed ID: 6856165 [TBL] [Abstract][Full Text] [Related]
20. [Immunostimulation in the treatment of chronic joint rheumatism (author's transl)]. Taube H MMW Munch Med Wochenschr; 1977 Nov; 119(46):1505-8. PubMed ID: 414083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]